More on PTEO
Financials
News
Click line-items for a historical chart and %
| Net loss attributable to Proteo, Inc. | -90.5K |
| Depreciation | |
| Bad debt expense | |
| Loss on disposal of equipment | |
| Foreign currency transaction losses (gains) | 34.95K |
| Research supplies | 142.17K |
| Prepaid expenses and other current assets | |
| Accounts payable and accrued liabilities | -142.33K |
| Deferred fees | -51.27K |
| Accrued licensing fees | |
| NET CASH USED IN OPERATING ACTIVITIES | |
| Acquisition of property and equipment | |
| Cash of reorganized entity | |
| NET CASH USED IN INVESTING ACTIVITIES | |
| Proceeds from issuance of common stock | |
| Proceeds from subscribed common stock and issuance of preferred stock to related party | |
| NET CASH PROVIDED BY FINANCING ACTIVITIES | |
| EFFECT OF FOREIGN CURRENCY EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS | |
| NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | -89.15K |
| CASH AND CASH EQUIVALENTS--BEGINNING OF PERIOD | 237.29K |
| CASH AND CASH EQUIVALENTS--END OF PERIOD | 148.14K |
